137 related articles for article (PubMed ID: 28659250)
1. Cutaneous Kaposi sarcoma during treatment with superpotent topical steroids and methotrexate for bullous pemphigoid: three cases.
Binois R; Nadal M; Esteve E; De Muret A; Kerdraon R; Gheit T; Tommasino M; Gaboriaud P; Touze A; Samimi M
Eur J Dermatol; 2017 Aug; 27(4):369-374. PubMed ID: 28659250
[TBL] [Abstract][Full Text] [Related]
2. Combined treatment with low-dose methotrexate and initial short-term superpotent topical steroids in bullous pemphigoid: an open, multicentre, retrospective study.
Du-Thanh A; Merlet S; Maillard H; Bernard P; Joly P; Estève E; Richard MA; Pauwels C; Ingen-Housz-Oro S; Guillot B; Dereure O
Br J Dermatol; 2011 Dec; 165(6):1337-43. PubMed ID: 21777222
[TBL] [Abstract][Full Text] [Related]
3. Kaposi Sarcoma Associated With Iatrogenic Immunosuppression: A Rare Complication of Bullous Pemphigoid Treatment.
Tremblay C; Friedmann D
J Cutan Med Surg; 2017; 21(5):449-451. PubMed ID: 28580800
[TBL] [Abstract][Full Text] [Related]
4. [Kaposi's disease: an unusual side-effect of topical corticosteroids].
Boudhir H; Mael-Ainin M; Senouci K; Hassam B; Benzekri L
Ann Dermatol Venereol; 2013; 140(6-7):459-61. PubMed ID: 23773746
[TBL] [Abstract][Full Text] [Related]
5. [Cutaneous infections in bullous pemphigoid patients treated with topical corticosteroids].
Boughrara Z; Ingen-Housz-Oro S; Legrand P; Duong TA; Roujeau JC
Ann Dermatol Venereol; 2010 May; 137(5):345-51. PubMed ID: 20470914
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune bullous diseases in non-HIV Kaposi's sarcoma: a retrospective study in a large cohort of patients.
Tourlaki A; Genovese G; Guanziroli E; Scoppio BM; Berti E; Brambilla L
J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1777-1783. PubMed ID: 29729120
[TBL] [Abstract][Full Text] [Related]
7. Kaposi's sarcoma after immunosuppressive therapy for bullous pemphigoid.
Scaparro E; Borghi S; Rebora A
Dermatologica; 1984; 169(3):156-9. PubMed ID: 6383896
[TBL] [Abstract][Full Text] [Related]
8. Kaposi's sarcoma resolves after sirolimus therapy in a patient with pemphigus vulgaris.
Saggar S; Zeichner JA; Brown TT; Phelps RG; Cohen SR
Arch Dermatol; 2008 May; 144(5):654-7. PubMed ID: 18490593
[TBL] [Abstract][Full Text] [Related]
9. Serological and immunohistochemical detection of human herpesvirus 8 in Kaposi's sarcoma after immunosuppressive therapy for bullous pemphigoid.
Sato-Matsumura KC; Matsumura T; Nabeshima M; Katano H; Sata T; Koizumi H
Br J Dermatol; 2001 Oct; 145(4):633-7. PubMed ID: 11703292
[TBL] [Abstract][Full Text] [Related]
10. Kaposi's sarcoma associated with immunosuppression for bullous pemphigoid.
Halpern SM; Parslew R; Cerio R; Kirby JT; Sharpe GR
Br J Dermatol; 1997 Jul; 137(1):140-3. PubMed ID: 9274643
[TBL] [Abstract][Full Text] [Related]
11. Extensive cutaneous iatrogenic Kaposi's sarcoma after bullous pemphigoid treatment with oral methylprednisolone: a rare Chinese case report.
Chen SA; Wang LT; Chen ZH; Yang FP; Zhu QY; Chen HY; Luo XQ
J Int Med Res; 2021 Jan; 49(1):300060520982829. PubMed ID: 33496629
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of bullous pemphigoid with low-dose methotrexate].
Böhm I; Bauer R
Hautarzt; 1997 Dec; 48(12):910-4. PubMed ID: 9486363
[TBL] [Abstract][Full Text] [Related]
13. Treatment of bullous pemphigoid with topical clobetasol propionate.
Westerhof W
J Am Acad Dermatol; 1989 Mar; 20(3):458-61. PubMed ID: 2645323
[TBL] [Abstract][Full Text] [Related]
14. Tinea incognito in an old patient with bullous pemphigoid receiving topical high potency steroids.
Liu ZH; Shen H
J Mycol Med; 2015 Sep; 25(3):245-6. PubMed ID: 26278826
[No Abstract] [Full Text] [Related]
15. Kaposi sarcoma in an patient with atopic dermatitis treated with ciclosporin.
Wall D; McMenamin M; O'Mahony D; Irvine AD
BMJ Case Rep; 2013 Nov; 2013():. PubMed ID: 24265347
[TBL] [Abstract][Full Text] [Related]
16. Kaposi sarcoma development following microscopic polyangiitis treatment.
Biricik M; Eren M; Bostan F; Yılmaz Ü; İnci A
Saudi J Kidney Dis Transpl; 2019; 30(2):537-539. PubMed ID: 31031393
[TBL] [Abstract][Full Text] [Related]
17. [Prospective study of treatment of bullous pemphigoid by a class I topical corticosteroid].
Zimmermann R; Faure M; Claudy A
Ann Dermatol Venereol; 1999 Jan; 126(1):13-6. PubMed ID: 10095883
[TBL] [Abstract][Full Text] [Related]
18. A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study.
Joly P; Roujeau JC; Benichou J; Delaporte E; D'Incan M; Dreno B; Bedane C; Sparsa A; Gorin I; Picard C; Tancrede-Bohin E; Sassolas B; Lok C; Guillaume JC; Doutre MS; Richard MA; Caux F; Prost C; Plantin P; Chosidow O; Pauwels C; Maillard H; Saiag P; Descamps V; Chevrant-Breton J; Dereure O; Hellot MF; Esteve E; Bernard P
J Invest Dermatol; 2009 Jul; 129(7):1681-7. PubMed ID: 19177141
[TBL] [Abstract][Full Text] [Related]
19. Low-dose oral pulse methotrexate as monotherapy in elderly patients with bullous pemphigoid.
Heilborn JD; Ståhle-Bäckdahl M; Albertioni F; Vassilaki I; Peterson C; Stephansson E
J Am Acad Dermatol; 1999 May; 40(5 Pt 1):741-9. PubMed ID: 10321603
[TBL] [Abstract][Full Text] [Related]
20. Bullous pemphigoid treated by topical corticosteroids.
Paquet P; Richelle M; Lapiere CM
Acta Derm Venereol; 1991; 71(6):534-5. PubMed ID: 1685838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
